Top Market Shifts Transforming the Community Oncology Services Market Landscape: Key Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Community Oncology Services Market Through 2025?
The sphere of community oncology services has witnessed robust expansion lately, projecting an increase from its 2024 valuation of $50.54 billion to $54.25 billion in 2025, thus reflecting a compound annual growth rate (CAGR) of 7.3%. This upward trajectory observed during the preceding years stems from elevated spending on healthcare provisions, the swift expansion of the aging demographic, and modifications within health insurance frameworks.

What's the Projected Size of the Global Community Oncology Services Market by 2029?
Anticipation points toward substantial expansion within the community oncology services sector over the forthcoming years, projecting a market valuation of $74.67 billion by 2029, achieved through a consistent annual growth rate of 8.3%. This upward trajectory across the projection horizon is fueled by several factors, notably the rising incidence of malignant diseases, shifts in societal habits, and augmented capital allocation toward medical facilities. Key developments set to shape this period include an amplified emphasis on delivering care via remote means, the establishment of strategic alliances, the creation of tailored service blueprints, leaps forward in technology, and increased activity in the realm of corporate takeovers and integrations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/community-oncology-services-global-market-report

Top Growth Drivers in the Community Oncology Services Industry: What's Accelerating the Market?
The prospect of more affordable healthcare delivery within community oncology facilities is projected to elevate the need for community oncology services overall, stemming from the inherent cost efficiency of these settings compared to traditional hospital environments. Evidence from the Community Oncology Alliance indicates a substantial difference in per-patient, per-month expenses for managing various cancers; community-based clinics (CCs) incurred approximately $12,000, while hospital-based oncology clinics (HCs) incurred close to $20,000. Moreover, when zeroing in on chemotherapy specifically, the monthly outlay per patient in the community reached nearly $5,000, contrasting sharply with the roughly $8,500 billed in hospital settings, thus suggesting that the inherent fiscal advantages of community oncology centers will serve as a significant impetus for market expansion throughout the projected period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3369&type=smp

What Trends Will Shape the Community Oncology Services Market Through 2029 and Beyond?
The community oncology services sector is witnessing substantial growth in popularity, prompting major corporations to engage in diverse mergers and cooperative research ventures aimed at broadening their service portfolios. A prime illustration of this activity occurred in April of 2023 when AmerisourceBergen Corporation, an entity specializing in wholesale distribution based in the US, alongside the American private equity firm TPG, successfully took over OneOncology for a sum reaching $2.1 billion. This strategic procurement empowered both TPG and AmerisourceBergen, allowing them to reinforce their foothold within the specialty practice network and amplify the solutions they provide within the field of oncology. OneOncology, a firm also situated in the United States, dedicates its efforts to revolutionizing the patient journey and addressing the challenges confronting community-based oncology, all while maintaining a leading position in the provision of cancer treatment.

What Are the Main Segments in the Community Oncology Services Market?
The community oncology servicesmarket covered in this report is segmented -

1) By Type: Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics
2) By Cancer Type: Breast Cancer, Lung Cancer, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Blood Cancer, Colorectal Cancer, Other Cancer Types
3) By Therapy Type: Medical Oncology, Radiation Oncology, Surgical Oncology, Other Therapies

Subsegments:
1) By Small Community Oncology Clinics: Independent Oncology Practices; Single-Physician Oncology Offices; Community-Based Cancer Screening and Prevention Services
2) By Medium Community Oncology Clinics: Multi-Physician Oncology Practices; Integrated Community Cancer Centers; Outpatient Treatment Facilities; Community-Based Clinical Trials
3) By Large Community Oncology Clinics: Comprehensive Cancer Centers; Academic-affiliated Community Oncology Practices; Multi-disciplinary Treatment Centers; Specialized Oncology Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3369&type=smp

Which Top Companies are Driving Growth in the Community Oncology Services Market?
Major companies operating in the community oncology services market include The US Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute (FCS), The Oncology Institute, Community Care Physicians, P.C. (CCP), GenesisCare, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Nanjing Legend Pharmaceutical & Chemical Co., Ltd, Zai Labare, Taxane HealthCare Pvt Ltd, Getwell Oncology, Novartis Oncology, Celgene, Johnson & Johnson, Janssen Pharma, Pharmacyclics, Healthkind Labs Pvt Ltd, Arlak Biotech, SwisscheM Healthcare Pvt Ltd, Apikos Pharma, Kolaz Biotech, Quironsalud Proton Therapy Centre, The London Clinic England, Institut Gustave Roussy, Netherlands Cancer Institute, European Medical Center, Yauza Medical Center, Celon Pharma, Nebraska Cancer Specialists, Tufts Medical Center, Doctors Medical Center, Oncology Specialists SC, Baptist Cancer Center, Mayo Clinic, Cleveland Clinic, Fred Hutchinson Cancer Research Center, The University of Texas Southwestern Medical Center, Abramson Cancer Center, McKesson Corporation, TUTEUR Argentina, Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma, King Hussein Cancer Center (KHCC), Princess Noorah Oncology Center (PNOC), King Abdulaziz Medical City, King Faisal Specialist Hospital and Research Centre, King Fahd Specialist Hospital, Prince Sultan Medical Military City, King Saud Medical City, King Abdullah Medical City, Tawam Hospital, Icon Oncology, Eurolab Science Laboratuvar, Yemaachi Biotechnology, Regal Pharmaceuticals Limited, Ocean Road Cancer Institute

Which Regions Will Dominate the Community Oncology Services Market Through 2029?
North America was the largest region in the community oncology services market in 2024. Western Europe was the second largest region in the global oncology services market. The regions covered in the community oncology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3369

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.